Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
0.825
-0.046 (-5.23%)
At close: Dec 5, 2025, 4:00 PM EST
0.880
+0.055 (6.67%)
After-hours: Dec 5, 2025, 7:59 PM EST
Salarius Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 5 | 3 | 3 | 3 | 22 | 22 | |
| Market Cap Growth | 138.00% | 3.58% | -26.56% | -84.44% | 3.42% | 41.29% | |
| Enterprise Value | 0 | -0 | -5 | -13 | -10 | 13 | |
| Last Close Price | 0.82 | 27.60 | 78.00 | 183.60 | 1486.80 | 2730.00 | |
| PS Ratio | - | - | - | - | 12.17 | 4.14 | |
| PB Ratio | 0.18 | 1.75 | 0.48 | 0.34 | 0.58 | 0.98 | |
| P/TBV Ratio | 1.14 | 1.75 | 0.48 | 0.34 | 0.75 | 1.63 | |
| EV/Sales Ratio | - | - | - | - | - | 2.46 | |
| Debt / Equity Ratio | - | 0.15 | 0.06 | - | - | 0.02 | |
| Asset Turnover | - | - | - | - | 0.06 | 0.27 | |
| Quick Ratio | 2.60 | 1.61 | 4.54 | 3.22 | 13.84 | 5.40 | |
| Current Ratio | 3.28 | 1.98 | 5.02 | 3.40 | 14.29 | 5.70 | |
| Return on Equity (ROE) | -139.55% | -164.02% | -160.07% | -128.73% | -41.94% | -44.91% | |
| Return on Assets (ROA) | -69.91% | -74.59% | -75.90% | -51.76% | -24.35% | -25.07% | |
| Return on Capital (ROIC) | -92.78% | -98.05% | -100.98% | -58.48% | -26.10% | -28.86% | |
| Return on Capital Employed (ROCE) | -131.10% | -379.30% | -243.90% | -221.20% | -33.10% | -35.10% | |
| Earnings Yield | -103.48% | -210.27% | -489.96% | -906.80% | -56.99% | -33.94% | |
| FCF Yield | -91.67% | -170.66% | -501.81% | -504.79% | -45.53% | -47.61% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.